Douglas J Swirsky
CIK 1375884 · View on SEC EDGAR ↗
First SEC filing: March 19, 2026 · Latest: March 19, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | MXCT | S | 10,142 | $0.82 | $8,316 | 151,669 Direct | -6.27% | Disposed | 68.3% (price as of 2026-08-21) |
| Aug. 13, 2025 | MXCT | P | 50,000 | $1.29 | $64,500 | 161,811 Direct | +44.72% | Acquired | 7.0% (price as of 2026-08-21) |
| March 18, 2025 | MXCT | S | 6,939 | $3.18 | $22,066 | 111,811 Direct | -5.84% | Disposed | -56.6% (price as of 2026-08-21) |
| Sept. 14, 2021 | CLRB | P | 25,000 | $1.04 | $26,000 | 25,000 Direct | — | Acquired | -99.2% (price as of 2026-08-21) |
| Jan. 29, 2019 | IRD | P | 50,000 | $0.63 | $31,500 | 50,000 Direct | — | Acquired | -86.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 7, 2026 | CLRB | Stock option (right to buy) | Common stock (37,500) | $2.70 | July 7, 2036 | 37,500 | Acquired |
| March 14, 2025 | MXCT | Employee Stock Option (right to buy) | Common Stock (150,000) | $3.29 | March 13, 2035 | 150,000 | Acquired |
| Feb. 14, 2025 | CLRB | Stock option (right to buy) | Common Stock (90,000) | $0.29 | Feb. 14, 2035 | 90,000 | Acquired |
| June 14, 2024 | CLRB | Stock option (right to buy) | Common Stock (90,000) | $2.58 | Dec. 22, 2033 | 90,000 | Acquired |
| March 15, 2024 | MXCT | Employee Stock Option (right to buy) | Common Stock (225,000) | $4.31 | March 14, 2034 | 225,000 | Acquired |
| June 28, 2023 | CLRB | Stock option (right to buy) | Common Stock (37,500) | $1.85 | June 28, 2033 | 37,500 | Acquired |
| March 27, 2023 | MXCT | Employee Stock Option (right to buy) | Common Stock (350,000) | $4.11 | March 26, 2033 | 350,000 | Acquired |
| June 24, 2022 | CLRB | Stock option (right to buy) | Common Stock | — | June 24, 2032 | 11,700 | Acquired |
| June 30, 2021 | CLRB | Stock option (right to buy) | Common Stock (117,000) | $1.19 | June 30, 2031 | 117,000 | Acquired |
| Sept. 1, 2020 | MTVA | Non-qualified stock option (right to buy) | Common Stock (60,000) | $6.04 | Sept. 1, 2030 | 60,000 | Acquired |
| June 24, 2020 | CLRB | Stock option (right to buy) | Common Stock (80,000) | $1.28 | June 24, 2030 | 80,000 | Acquired |
| June 13, 2019 | CLRB | Stock option (right to buy) | Common Stock (9,750) | $2.15 | June 13, 2029 | 9,750 | Acquired |
| Nov. 14, 2018 | IRD | Stock Option (right to buy) | Common Stock (500,000) | $1.09 | Nov. 14, 2028 | 500,000 | Acquired |
| Oct. 12, 2018 | CLRB | Stock option (right to buy) | Common Stock (19,500) | $2.61 | Oct. 12, 2028 | 19,500 | Acquired |
| Jan. 2, 2018 | IRD | Stock Option (right to buy) | Common Stock (250,000) | $2.10 | Jan. 2, 2028 | 250,000 | Acquired |
| May 31, 2017 | CLRB | Stock option (right to buy) | Common Stock (10,000) | $1.74 | May 31, 2027 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
IRD
President & CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $343,542 | — | — | — | — | — | $1,228,986 | $1,572,528 |
MXCT
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $491,000 | — | $246,750 | $269,914 | $201,893 | — | $15,500 | $1,225,057 |
| 2023 | $326,129 | — | — | $684,923 | $161,500 | — | $17,382 | $1,189,934 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.